1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Zoetis
  6. Summary
    ZTS   US98978V1035

ZOETIS

(ZTS)
  Report
Delayed Nyse  -  04:03 2022-08-08 pm EDT
174.01 USD   -0.34%
08/05ZOETIS : Full Transcript Second Quarter 2022
PU
08/04ZOETIS INC. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
AQ
08/04TRANSCRIPT : Zoetis Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/02/2022 08/03/2022 08/04/2022 08/05/2022 08/08/2022 Date
178.83(c) 180.16(c) 174.31(c) 174.61(c) 174.01 Last
1 180 167 1 659 911 2 391 121 1 523 552 1 231 699 Volume
-0.51% +0.74% -3.25% +0.17% -0.34% Change
More quotes
Estimated financial data (e) (USD)
Sales 2022 8 264 M - -
Net income 2022 2 193 M - -
Net Debt 2022 2 577 M - -
P/E ratio 2022 37,1x
Yield 2022 0,72%
Sales 2023 8 934 M - -
Net income 2023 2 401 M - -
Net Debt 2023 1 001 M - -
P/E ratio 2023 33,5x
Yield 2023 0,82%
Capitalization 81 461 M 81 461 M -
EV / Sales 2022 10,2x
EV / Sales 2023 9,23x
Nbr of Employees 12 100
Free-Float 92,4%
More Financials
Company
Zoetis Inc. specializes in developing, manufacturing and marketing of animal health products. Net sales break down by activity as follows: - pets (54.7%): cats and dogs (94.1% of net sales) and horses (5.9%); - livestock (44.1%): cattle (53% of sales), swine (21.1%), poultry (18.3%), fish (5%) and other (1.2%); - other (1.2%). Net sales break down by family of products into vaccines (22.1%), anti-infectives... 
Sector
Pharmaceuticals
Calendar
11/03Earnings Release
More about the company
Ratings of Zoetis
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B
More Ratings
All news about ZOETIS
08/05ZOETIS : Full Transcript Second Quarter 2022
PU
08/04ZOETIS INC. Management's Discussion and Analysis of Financial Condition and Results of..
AQ
08/04TRANSCRIPT : Zoetis Inc., Q2 2022 Earnings Call, Aug 04, 2022
CI
08/04Zoetis Reports Higher Q2 Adjusted Profit, Revenue; Updates 2022 Outlook
MT
08/04ZOETIS : Q2 Earnings Snapshot
AQ
08/04ZOETIS : Announces Second Quarter 2022 Results - Form 8-K
PU
08/04Earnings Flash (ZTS) ZOETIS Reports Q2 EPS $1.20
MT
08/04Earnings Flash (ZTS) ZOETIS Posts Q2 Revenue $2.05B
MT
08/04Zoetis Announces Second Quarter 2022 Resultsá
BU
08/04Zoetis Inc. Provides Earnings Guidance for the Full Year 2022
CI
08/04Zoetis Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 3..
CI
08/04Zoetis Cuts 2022 Adjusted. Earnings Guidance, Lowers High-End of Sales Range
DJ
08/04Zoetis 2Q Sales Rise, Driven by U.S. Growth
DJ
08/03Wheat Falls Amid Lack of Interest From Traders -- Daily Grain Highlights
DJ
08/02Wheat Falls as Crop Conditions Improve -- Daily Grain Highlights
DJ
More news
News in other languages on ZOETIS
08/04Zoetis annonce une hausse de son bénéfice ajusté et de son chiffre d'affaires au deuxiè..
08/04Earnings Flash (ZTS) ZOETIS affiche un chiffre d'affaires de 2,05 milliards de dollars ..
08/04Zoetis Inc. Fournit des prévisions de bénéfices pour l'année 2022 complète
08/04Zoetis Inc. annonce ses résultats pour le deuxième trimestre et le semestre clos le 30 ..
07/25Zoetis Inc. nomme Vanessa Broadhurst à son conseil d'administration
More news
Analyst Recommendations on ZOETIS
More recommendations
Chart ZOETIS
Duration : Period :
Zoetis Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ZOETIS
Short TermMid-TermLong Term
TrendsNeutralNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Last Close Price 174,01 $
Average target price 225,64 $
Spread / Average Target 29,7%
EPS Revisions
Managers and Directors
Kristin C. Peck Chief Executive Officer & Director
Wetteny Joseph CFO, EVP & Head-Business Development
Michael B. McCallister Non-Executive Chairman
Wafaa Mamilli Chief Information & Digital Officer
Robert J. Polzer Executive VP, President-Research & Development
Sector and Competitors
1st jan.Capi. (M$)
ZOETIS-28.45%81 742
ELANCO ANIMAL HEALTH INCORPORATED-31.50%9 216
DECHRA PHARMACEUTICALS PLC-32.81%4 903
BLUESTAR ADISSEO COMPANY-24.84%3 665
VIRBAC-12.60%3 183
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.-1.53%1 924